The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.
原文: https://www.cnbc.com/2026/02/03/novo-nordisk-2025-earnings-wegovy-ozempic.html
Last Update:
4 2 月, 2026
